Lifecore Biomedical Inc reports results for the quarter ended in May 31 - Earnings Summary

Lifecore Biomedical

29/08/2024 14:31

* Lifecore Biomedical Inc  LFCR.OQ  reported a quarterly
adjusted
loss of 17 cents​​ per share for the quarter ended May 31,
higher than the same quarter last year, when the company
reported EPS of -89 cents.  The lone analyst forecast for the
quarter was for a loss of 12 cents per share. 
    * Revenue rose 20.1% to $37.89 million from a year ago;
analysts
expected $35.02 million. 
    * Lifecore Biomedical Inc's reported EPS for the quarter was
a
loss of 19 cents​.
    * The company reported a quarterly loss of $7.08 million.
    * Lifecore Biomedical Inc shares had fallen by 22.6% this
quarter and lost 35.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 20%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "hold"

Wall Street's median 12-month price target for Lifecore
Biomedical Inc is $6.00 
This summary was machine generated from LSEG data August 29 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 May. 31 2024      -0.12          -0.17          Missed
 Feb. 29 2024      -0.06                         
 Nov. 30 2023      -0.07                         
 Aug. 31 2023      -0.26